NERATINIB Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A quinoline compound having a cyano group at the 3-position, a 3-chloro-4-(2-pyridylmethoxy)anilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an ethoxy group at the 7-position. (Chemical Entities of Biological Interest Ontology, CHEBI_61397)
External Link https://dgidb.org/results?searchType=drug&searchTerms=NERATINIB
Similar Terms
Downloads & Tools

Genes

13 interacting proteins for the NERATINIB drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
HERC2 HECT and RLD domain containing E3 ubiquitin protein ligase 2 8.14338
ERBB2 erb-b2 receptor tyrosine kinase 2 0.73839
CBL Cbl proto-oncogene, E3 ubiquitin protein ligase 0.407169
PGR progesterone receptor 0.10715
EGFR epidermal growth factor receptor 0.0979445
BRAF B-Raf proto-oncogene, serine/threonine kinase 0.0740308
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 0.0721931
ERBB4 erb-b2 receptor tyrosine kinase 4 0.0690117
PTEN phosphatase and tensin homolog 0.0528791
ESR2 estrogen receptor 2 (ER beta) 0.0447439
ESR1 estrogen receptor 1 0.0328362
KDR kinase insert domain receptor 0.0200576
YES1 YES proto-oncogene 1, Src family tyrosine kinase 0.0191159